159 related articles for article (PubMed ID: 14612899)
1. Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing.
Iwadate Y; Fujimoto S; Namba H; Yamaura A
Br J Cancer; 2003 Nov; 89(10):1896-900. PubMed ID: 14612899
[TBL] [Abstract][Full Text] [Related]
2. Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis.
Iwadate Y; Fujimoto S; Yamaura A
Int J Mol Med; 2002 Aug; 10(2):187-92. PubMed ID: 12119557
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme.
Gruber ML; Glass J; Choudhri H; Nirenberg A
Am J Clin Oncol; 1998 Aug; 21(4):338-40. PubMed ID: 9708629
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme.
Marx GM; Pavlakis N; McCowatt S; Boyle FM; Levi JA; Bell DR; Cook R; Biggs M; Little N; Wheeler HR
J Neurooncol; 2001 Aug; 54(1):31-8. PubMed ID: 11763420
[TBL] [Abstract][Full Text] [Related]
5. Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.
Silvani A; Gaviani P; Lamperti EA; Eoli M; Falcone C; Dimeco F; Milanesi IM; Erbetta A; Boiardi A; Fariselli L; Salmaggi A
J Neurooncol; 2009 Aug; 94(1):57-62. PubMed ID: 19212704
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.
Choi IS; Lee SH; Kim TY; Bang JS; Paek SH; Kim S; Kim IH; Heo DS; Bang YJ; Kim DG; Jung HW; Kim NK
J Neurooncol; 2002 Nov; 60(2):171-6. PubMed ID: 12635665
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.
Ellingson BM; Sahebjam S; Kim HJ; Pope WB; Harris RJ; Woodworth DC; Lai A; Nghiemphu PL; Mason WP; Cloughesy TF
AJNR Am J Neuroradiol; 2014 Apr; 35(4):673-9. PubMed ID: 24136647
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
Varveris H; Petinelli E; Stratakis J; Mazonakis M
Oncol Rep; 2008 Feb; 19(2):447-55. PubMed ID: 18202794
[TBL] [Abstract][Full Text] [Related]
9. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).
Gross MW; Altscher R; Brandtner M; Häusser-Mischlich H; Kiricuta IC; Siegmann AD; Engenhart-Cabillic R
Strahlenther Onkol; 2001 Dec; 177(12):656-61. PubMed ID: 11789404
[TBL] [Abstract][Full Text] [Related]
10. ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.
Gwak HS; Youn SM; Kwon AH; Lee SH; Kim JH; Rhee CH
J Neurooncol; 2005 Nov; 75(2):173-80. PubMed ID: 16132508
[TBL] [Abstract][Full Text] [Related]
11. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
Simpson L; Galanis E
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
[TBL] [Abstract][Full Text] [Related]
12. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
[TBL] [Abstract][Full Text] [Related]
13. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
Chamberlain MC; Tsao-Wei DD
Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
[TBL] [Abstract][Full Text] [Related]
14. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
Madajewicz S; Chowhan N; Tfayli A; Roque C; Meek A; Davis R; Wolf W; Cabahug C; Roche P; Manzione J; Iliya A; Shady M; Hentschel P; Atkins H; Braun A
Cancer; 2000 May; 88(10):2350-6. PubMed ID: 10820358
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
[TBL] [Abstract][Full Text] [Related]
16. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
Rezaei V; Rabiee A; Khademi F
J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
Simon JM; Noël G; Chiras J; Hoang-Xuan K; Delattre JY; Baillet F; Mazeron JJ
Radiother Oncol; 2003 Apr; 67(1):45-51. PubMed ID: 12758239
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting partial regression of glioblastoma multiforme achieved by edotecarin: case report.
Vrdoljak E; Boban M; Saratlija-Novaković Z; Jović J
Croat Med J; 2006 Apr; 47(2):305-9. PubMed ID: 16625697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]